Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection | MicrobiomeTrials← Back to trialsNCT07519330
Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-14Est. Completion: 2028-02-28
Enrollment target: 45 participants Locations- Chongqing University Three Gorges Hospital, Chongqing, Chongqing Municipality, China
Other microbiome trials you might be interested in
Chronic Hepatitis B e Antigen PositiveChronic Hepatitis B e Antigen Negative
Background:
\- Chronic infection with the hepatitis B virus may lead to cirrhosis, liver disease, and cancer of the liv…
Bethesda, United States
Hepatitis CHepatitis B
This study will evaluate hepatitis C virus (HCV) infection in blood donors who test positive for antibodies to this viru…
Bethesda, United States
TERMINATED
This Phase 1/2a multiple part study is a first time-in-human (FTIH) study designed to evaluate the safety, tolerability,…
Calgary, CanadaCompleted May 19, 2025